China Shineway Pharmaceutical Group Limited (C1S) — Cash Flow Reinvestment Rate

Latest as of June 2023: 0.17x

China Shineway Pharmaceutical Group Limited (C1S) has a Cash Flow Reinvestment Rate of 0.17x as of June 2023, reinvesting €26.64 Million (capex €24.57 Million plus investments €2.06 Million) from operating cash flow of €160.69 Million. Check C1S cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.17x
(Capex + Investments) / Operating CF

Total Reinvested

€26.64 Million
Capex + Investments

Operating Cash Flow

€160.69 Million
EUR

Capital Expenditures

€24.57 Million
EUR

China Shineway Pharmaceutical Group Limited Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for China Shineway Pharmaceutical Group Limited across 13 annual periods. Explore China Shineway Pharmaceutical Group Limi debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for China Shineway Pharmaceutical Group Limited (2013–2025)

Year-by-year capital reinvestment analysis for China Shineway Pharmaceutical Group Limited. For live market cap and broader valuation context, see C1S stock market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.30x €348.24 Million €1.17 Billion €197.91 Million ▼ -37.4%
2024 0.48x €457.50 Million €963.13 Million €140.11 Million ▲ +186.1%
2023 0.17x €154.86 Million €932.63 Million €144.32 Million ▲ +35.4%
2022 0.12x €136.13 Million €1.11 Billion €129.46 Million ▼ -15.7%
2021 0.15x €102.37 Million €703.15 Million €93.63 Million ▼ -15.4%
2020 0.17x €109.93 Million €638.57 Million €66.03 Million ▼ -40.4%
2019 0.29x €106.33 Million €368.00 Million €88.40 Million ▲ +13.1%
2018 0.26x €136.07 Million €532.59 Million €127.34 Million ▲ +24.7%
2017 0.20x €100.56 Million €490.65 Million €91.83 Million ▼ -19.4%
2016 0.25x €186.50 Million €733.53 Million €106.79 Million ▲ +24.8%
2015 0.20x €151.71 Million €744.71 Million €106.56 Million ▼ -12.1%
2014 0.23x €179.20 Million €773.16 Million €104.18 Million ▼ -60.9%
2013 0.59x €308.46 Million €519.89 Million €261.89 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow